(3-Acryloxypropyl)tris(trimethylsiloxy)silane inhibited with MEHQ tech-95, 95+%, 5g

1-(Aminomethyl)cyclohexanamine dihydrochloride, 95.0%, 100mg

Ethyl N-Boc-4-oxo-pyrrolidine-3-carboxylate, 95.0%, 500g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-bromophenyl)propanoic acid, 97%, 500mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(thiophen-2-yl)acetic acid, 95.0%, 100mg

Methyl 5-amino-2-(trifluoromethyl)benzoate, 97%, 250mg

4-Fluorophenylhydrazine, 90.0%, 250mg

DLin-KC2-DMA, 100mg

4'-n-Octylacetophenone>97.0%(GC)25g

5,6-Dimethylnicotinonitrile, 95.0%, 1g

N,N'-Dimethylquinacridone>96.0%(HPLC)1g

Tetrabutylammonium p-Nitrophenoxide>98.0%(HPLC)(T)25g

1-METHYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE-4-CARBOXYLIC ACID, 95.0%, 250mg